|
Synonyms: Lu AG13909 | Lu-AG13909
Compound class:
Antibody
Comment: Asedebart (Lu AG13909) is a humanized monoclonal antibody that binds (neutralizes) human ACTH (corticotropin) by acting as a ligand trap. Peptide matches for the heavy and light chains of asedebart are claimed in patent US10047157B2, and form the antibody named Ab13.H therein [1]. The antibody is intended to block ACTH-mediated activation of melanocortin receptors in the adrenal glands, as a mechanism to reduce the overproduction of cortisol and aldosterone in ACTH‑dependent conditions such as Cushing's disease/syndrome.
|
| References |
|
1. Feldhaus AL, Garcia-Martinez LF, Dutzar BH, Allison DS, Anderson KO, Ojala EW, Fan P, Karasek C, Mulligan JA, Mitchell DM et al.. (2018)
Humanized anti-ACTH antibodies and use thereof. Patent number: US10047157B2. Assignee: H Lundbeck AS. Priority date: 18/12/2015. Publication date: 14/08/2018. |
|
2. Graves LE, Falhammar H. (2026)
Advances in pharmacological treatment for congenital adrenal hyperplasia. Curr Opin Pediatr, 38 (4): 434-439. [PMID:42234636] |